Studies indicate that patients with APOE4 and TDP-43 pathology exhibit faster cognitive decline than those with amyloid pathology alone, suggesting that TDP-43 may represent an additional risk factor for AD. This evidence concerns the gene TARDBP and Alzheimer disease.